Resultaattype

U heeft gezocht op: Ytterbium+triacetate+hydrate

54  results were found

General Description of an Application

General Description of an Application Application Date: 05.03.2013 Page 1 of 5 Quantitative analysis of hydrogen peroxide Application Date: 05.03.2013 Page 2 of 5 Content Content .......................................................................

Nieuws

Nieuws Production magazine 2023-24 Wide range of Pharma-grade sterilisation packaging (covers pouches bags etc) made of Tyvek from Keystone Focus: Production – 2022-2023 CES & Safety Application notes library Your source for production related tec...

Purification

Purification Productselectie Tris and biobuffers pH adjusters (acid) pH adjusters (base) Salts Chromatography media Cleaning reagents

Downstream purification for gene therapy

Downstream purification for gene therapy With more than 30 years of chromatography experience developed products and services we have every solution to meet your needs. Our J.T.Baker® brand BAKERBOND™ chromatography resins have been used successfu...

Buffer management solutions

Buffer management solutions Buffers play a significant role in biopharmaceutical manufacturing. Typically representing a major component by volume used in downstream processing steps buffer preparation constitutes a significant proportion of a fac...

Avantor Production Chemicals

Avantor Production Chemicals Find everything you need for your biopharmaceutical production process. From purification to formulation and finish Avantor has it all. Fermentation and Cell Culture All additives such as amino acids minerals and vitam...

Upstream Gene Therapy Products & Solutions in Bioprocessing

Upstream Gene Therapy Products & Solutions in Bioprocessing Achieve optimal generation of gene therapy vectors with our non-viral transfection and viral transduction products. Avantor® can provide culture systems that support processes development...

Final fill for cell therapy

Final fill for cell therapy The cell therapy drug product is configured in different ways depending on the required delivery of the cells/tissues. For example delivery of chondrocytes for cartilage repair is administered by an injection. Expanded ...

Sanborn Manufacturing Facility

Sanborn Manufacturing Facility The HEPES manufacturing suite at our 60000 sq. ft. manufacturing facility in Sanborn NY USA. Core Capabilities Custom manufacturing of biological buffers amino acid derivatives and custom antibiotic solutions Industr...

Downstream purification for recombinant proteins

Downstream purification for recombinant proteins With more than 30 years of chromatography experience developed products and services we have every solution to meet your needs. Our J.T.Baker® brand BAKERBOND™ chromatography resins have been used s...

Final fill for vaccines

Final fill for vaccines Progressing from the drug substance to the final injectable drug product requires final packaging vials and stoppers that meet a number of quality requirements. To meet these requirements products must be prepared in an ISO...

Montreal Manufacturing Facility

Montreal Manufacturing Facility The off-loading manifold at our Montreal QC manufacturing facility which includes 8600 sq. ft. for manufacturing 2200 sq. ft. for quality control and a 22800 sq. ft. warehouse. Core Capabilities Production of labora...

Final fill for mAbs

Final fill for mAbs Progressing from the drug substance to the final injectable drug product requires final packaging vials and stoppers that meet a number of quality requirements. To meet these requirements products must be prepared in an ISO Cla...

Upstream processing for mAbs

Upstream processing for mAbs Developing and manufacturing mAbs has moved away from a dependency on raw materials of animal origin. Our biochemical components and supplements are animal component-free to meet the needs of these applications. Produc...

Back to Basics 2: Mobile Phase Selection In HPLC & UHPLC

Back to Basics 2: Mobile Phase Selection In HPLC & UHPLC Webinar Thursday 28th January 2021 15:00 to 16:00 CEST (Berlin Paris Madrid) Replay Mobile phase composition is a fundamental decision which has a major impact on the separation of analytes ...

Upstream processing for cell therapy

Upstream processing for cell therapy Compared to production volumes associated with other biologics (e.g. mAbs: 2000L to 10000L) cell therapy production volumes are more commonly between 1L to 10L. Even the quality parameters are different. Instea...
17 - 32 of 54